Ovid Therapeutics (OVID)
(Delayed Data from NSDQ)
$1.12 USD
+0.01 (0.90%)
Updated Sep 11, 2024 04:00 PM ET
After-Market: $1.12 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.12 USD
+0.01 (0.90%)
Updated Sep 11, 2024 04:00 PM ET
After-Market: $1.12 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Zacks News
Inovio (INO) Stock Up YTD on Coronavirus Vaccine Efforts
by Zacks Equity Research
Inovio (INO) is developing INO-4800, its DNA vaccine to enter clinical testing soon, against COVID-19. The company's vaccine portfolio holds potential amid competition.
Will Ovid Therapeutics Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor Ovid Therapeutics.
Will Ovid Therapeutics Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor Ovid Therapeutics.
OVID THERAPEUTC Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
OVID THERAPEUTC Sees Hammer Chart Pattern: Time to Buy?
OVID THERAPEUTC Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
OVID THERAPEUTC has been struggling lately, but the selling pressure may be coming to an end soon.